AmerisourceBergen

company

About

AmerisourceBergen is a global healthcare company that advances the development and delivery of pharmaceuticals and healthcare products.

Details

Last Funding Type
Post-IPO Secondary
Last Funding Money Raised
$500M
Industries
Emergency Medicine,Enterprise Software,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1907
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
nyse:ABC
Legal Name
AmerisourceBergen Corp.

AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. Their scale, their position in the healthcare industry, and the value they bring to the channel have all helped their business continue to succeed.

Headquartered in Valley Forge, Pennsylvania, AmerisourceBergen has locations around the world. It handles about 20% of all of the pharmaceuticals sold and distributed throughout the U.S.

They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers every day, they provide business support and consulting services to help their customers focus on their key strength—caring for patients.

AmerisourceBergen is committed to the safety and security of the nation’s pharmaceutical supply chain. They purchase all branded and generic pharmaceuticals only directly from the product’s manufacturer, except in the rare instance that they are required to do otherwise either by the manufacturer or a government agency.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$2.52B
AmerisourceBergen has raised a total of $2.52B in funding over 2 rounds. Their latest funding was raised on Nov 7, 2022 from a Post-IPO Secondary round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 7, 2022 Post-IPO Secondary $500M Detail
Mar 30, 2021 Post-IPO Debt $1.52B Detail
May 19, 2020 Post-IPO Debt $500M Detail
Apr 13, 1995 IPO Detail

Investments

Number of Investments
Number of Lead Investments
10
2
AmerisourceBergen has made 10 investments. Their most recent investment was on Oct 25, 2022, when WhizAI raised $6M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 25, 2022 WhizAI
Series A $6M Analytics Yes
Sep 29, 2022 WhizAI
Series A $8M Analytics
Jul 29, 2021 Secured Finance
Seed $4M Blockchain
Mar 3, 2021 TrakCel
Corporate Round Clinical Trials Yes
Mar 1, 2017 Forge
Series A $3M Finance

Employee Profiles

Number of Employee Profiles
33
AmerisourceBergen has 33 current employee profiles, including Board member Henry W. McGee
Board member
Executive
Executive
Executive
Executive

Exits

AmerisourceBergen has had 1 exits. AmerisourceBergen most notable exits include Profarma

Date Company Name Exit Type Industry
Nov 3, 2006 Profarma IPO Pharmaceutical Detail

Acquisition

AmerisourceBergen has acquired 23 organizations. Their most recent acquisition was Lash Group on Dec 1, 1998. They acquired Lash Group for 0.

Date Company Name
Industry Acquisition Type Price
Dec 1, 1998 Lash Group
Health Care acquisition Detail
Health Care acquisition Detail
Health Care acquisition $ 120M Detail
Information Technology acquisition $ 55M Detail
Jan 17, 2003 US Bioservices
Biopharma acquisition $ 160M Detail